These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 19544804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G, Reniers B, Murrer L, Lutgens L, Gurp EB, Pignol JP, Keller B, Beaulieu L, Verhaegen F.
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for 125 I prostate implants.
    Assam I, Vijande J, Ballester F, Pérez-Calatayud J, Poppe B, Siebert FA.
    Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O, Williamson JF, Todor D.
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [Abstract] [Full Text] [Related]

  • 6. Impact of interseed attenuation and tissue composition for permanent prostate implants.
    Carrier JF, Beaulieu L, Therriault-Proulx F, Roy R.
    Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563
    [Abstract] [Full Text] [Related]

  • 7. Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant.
    Afsharpour H, Pignol JP, Keller B, Carrier JF, Reniers B, Verhaegen F, Beaulieu L.
    Phys Med Biol; 2010 Aug 21; 55(16):4547-61. PubMed ID: 20668347
    [Abstract] [Full Text] [Related]

  • 8. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM, Rogers DW.
    Med Phys; 2010 Jan 21; 37(1):368-76. PubMed ID: 20175499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Brachytherapy; 2014 Jan 21; 13(6):603-10. PubMed ID: 24913435
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
    Collins Fekete CA, Plamondon M, Martin AG, Vigneault É, Verhaegen F, Beaulieu L.
    Med Phys; 2014 Oct 21; 41(10):101704. PubMed ID: 25281943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patient-specific Monte Carlo dose calculations for (103)Pd breast brachytherapy.
    Miksys N, Cygler JE, Caudrelier JM, Thomson RM.
    Phys Med Biol; 2016 Apr 07; 61(7):2705-29. PubMed ID: 26976478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.